Aquestive Therapeutics announced it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) for Anaphylm (dibutepinephrine) Sublingual Film, a noninvasive ...
Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional ...
Discusses FDA Complete Response Letter and Next Steps for Anaphylm Epinephrine Sublingual Film February 2, 2026 8:00 ...
Remember the X Gran Equator off-road SUV concept unveiled at the New York Auto Show in April of last year? Well, Genesis is ...
Well, this is unexpected. Not so much in that Genesis has unveiled a new concept car, as the brand is quite fond of making ...
Genesis unveils the X Skorpio Concept, an extreme off-roader that combines luxury and refinement with a V8 delivering an ...
Morning Overview on MSN
12 harmless-looking animals sending Americans to the ER every year
They look cute, familiar or downright boring, yet these creatures quietly help drive a national injury toll that sends ...
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ...
Health authorities have warned of an urgent recall of bread crumbs sold in Colorado due to potentially life-threatening ...
As part of the back-to-school rush, GoodRx, a platform for medication savings, reports the demand for epinephrine (EpiPen, EpiPen Jr, Adrenaclick, Auvi-Q) auto-injectors tends to spike in the summer ...
The FDA cited concerns about human factors in the use of Aquestive Therapeutics’ Anaphylm sublingual film for anaphylaxis and other type 1 allergic reactions in its complete response letter to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results